Groupe d'Etude en Oncologie du Quebec

Title	Liquid biopsy for Non-Small Cell Lung Cancer: comparing plasma cell-free DNA/RNA to tissue NGS to assesses turnaround time, patient distress and cost-effectiveness
Protocole ID	QC-LIQBIOP
ClinicalTrials.gov ID	n.d.
Cancer Type(s)	Non Small Cells - Lung
Phase	Other
Stage
Study Type
Drug
Institution	CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS 3755 rue de la Côte Ste. Catherine, Montréal, QC, H3T 1E2
City
Principal Investigator	Dr. Jason Agulnik
Coordinator	Goulnar Kasymjanova 514-340-8222 poste 24312
Status	Recruiting
Activation Date
Eligibility Criteria	Patients with suspected advanced non-squamous Non-Small Cell Lung Cancer (NSCLC), Stage III or IV who are eligible for a diagnostic biopsy procedure. No medical contraindications for diagnostic procedure Provide written informed consent in accordance with institutional guidelines.
Exclusion Criteria	Past medical history of other cancer within the last 3 years Tissue biopsy is not possible for any reason

Groupe d'étude en oncologie du Québec